We are in the midst of a revolution in our ability to understand the molecular basis of the skeletal dysplasias. Innovations in genome sequence analysis have provided the opportunity to identify the mutations associated with the 100+ clinically distinct skeletal dysplasias for which an associated gene has yet to be found. The clinical resources of the International Skeletal Dysplasia Registry, the largest worldwide registry of cases from skeletal dysplasia patients, are ideally suited for such studies, having both the depth and breadth of disorders that can be solved using a genomic approach. Each of the disorders to be studied will provide new insights into the complex biology of the skeleton, and will do so in a clinical context. Importantly, genomic approaches will allow us to define the genetic basis of disorders in which traditional genetic approaches are impossible, such as phenotypes produced by new dominant mutations.
In Specific Aim 1, we will study dominant disorders including acrodysostosis, SMD corner fracture type and forms of multiple epiphyseal dysplasia in which the known genes have been excluded.
In Specific Aim 2, recessively inherited phenotypes will be studied including asphyxiating thoracic dystrophy (ATD or Jeune syndrome), opsismodysplasia, a perinatal lethal phenotype with the spondylodysplastic group of disorders, and recessive forms of pseudoachondroplasia and spondyloepiphyseal dysplasia. The genes associated with all of these phenotypes will be defined by exome sequencing. Functional validation will identify the biochemical mechanisms associated with these disorders and begin to explore pathogenesis. The results will reveal new molecular mechanisms for the skeletal dysplasias and define the normal functions of the genes we identify.
The results of these studies will provide immediate translational benefit by providing accurate genetic counseling to families with these conditions as well as opportunities for genetic testing. The results will reveal new molecules and pathways essential for normal skeletal development as well as opportunities for mechanistic studies leading to rational strategies for therapies aimed at ameliorating these disorders.
|Duran, Ivan; Taylor, S Paige; Zhang, Wenjuan et al. (2016) Destabilization of the IFT-B cilia core complex due to mutations in IFT81 causes a Spectrum of Short-Rib Polydactyly Syndrome. Sci Rep 6:34232|
|Weinstein, Michael M; Kang, Taekyu; Lachman, Ralph S et al. (2016) Somatic mosaicism for a lethal TRPV4 mutation results in non-lethal metatropic dysplasia. Am J Med Genet A 170:3298-3302|
|Toriyama, Michinori; Lee, Chanjae; Taylor, S Paige et al. (2016) The ciliopathy-associated CPLANE proteins direct basal body recruitment of intraflagellar transport machinery. Nat Genet 48:648-56|
|Lee, Hane; Nevarez, Lisette; Lachman, Ralph S et al. (2015) A second locus for Schneckenbecken dysplasia identified by a mutation in the gene encoding inositol polyphosphate phosphatase-like 1 (INPPL1). Am J Med Genet A 167A:2470-3|
|Duran, Ivan; Nevarez, Lisette; Sarukhanov, Anna et al. (2015) HSP47 and FKBP65 cooperate in the synthesis of type I procollagen. Hum Mol Genet 24:1918-28|
|Schmidts, Miriam; Hou, Yuqing; CortÃ©s, Claudio R et al. (2015) TCTEX1D2 mutations underlie Jeune asphyxiating thoracic dystrophy with impaired retrograde intraflagellar transport. Nat Commun 6:7074|
|Taylor, S Paige; Dantas, Tiago J; Duran, Ivan et al. (2015) Mutations in DYNC2LI1 disrupt cilia function and cause short rib polydactyly syndrome. Nat Commun 6:7092|
|Murali, Chaya; Lu, James T; Jain, Mahim et al. (2014) Diagnosis of ALG12-CDG by exome sequencing in a case of severe skeletal dysplasia. Mol Genet Metab Rep 1:213-219|
|Saitta, Biagio; Passarini, Jenna; Sareen, Dhruv et al. (2014) Patient-derived skeletal dysplasia induced pluripotent stem cells display abnormal chondrogenic marker expression and regulation by BMP2 and TGFÎ²1. Stem Cells Dev 23:1464-78|
|Leddy, Holly A; McNulty, Amy L; Lee, Suk Hee et al. (2014) Follistatin in chondrocytes: the link between TRPV4 channelopathies and skeletal malformations. FASEB J 28:2525-37|
Showing the most recent 10 out of 13 publications